Predictive Oncology
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $345 | $278 | $419 | $335 |
Gross Profit | 148 | -38 | 69 | -71 |
EBITDA | -2,283 | -3,025 | -4,074 | -3,347 |
EBIT | -3,189 | -4,236 | -3,505 | |
Net Income | -3,181 | -4,218 | -3,475 | |
Net Change In Cash | 345 | 278 | 419 | 335 |
Free Cash Flow | -2,279 | -3,224 | -3,419 | -3,075 |
Cash | 3,078 | 5,331 | 5,197 | 8,728 |
Basic Shares | 6,396 | 4,664 | 4,062 | 4,062 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $1,780 | $1,505 | $1,420 | $1,252 |
Gross Profit | 1,145 | 1,000 | 933 | 805 |
EBITDA | -13,182 | -13,954 | -12,131 | -11,458 |
EBIT | -13,921 | -15,267 | -13,471 | -12,483 |
Net Income | -13,983 | -36,207 | -19,657 | -37,701 |
Net Change In Cash | 1,780 | 1,505 | 1,420 | 1,252 |
Cost of Revenue | 527 | |||
Free Cash Flow | -13,491 | -12,846 | -13,171 | -12,618 |
Cash | 8,728 | 22,071 | 28,202 | 678 |
Basic Shares | 4,014 | 3,649 | 2,743 | 597 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.48 |
2024-06-30 | -$0.68 |
2024-03-31 | -$1.03 |
2023-12-31 | -$0.85 |
